Tosu, Japan

Tatsuya Sakakura


Average Co-Inventor Count = 3.0

ph-index = 1


Company Filing History:


Years Active: 2024

Loading Chart...
1 patent (USPTO):Explore Patents

Title: **Tatsuya Sakakura: Innovator in Transdermal Delivery Systems**

Introduction

Tatsuya Sakakura, an inventive mind hailing from Tosu, Japan, has made his mark in the field of pharmaceuticals. As part of Hisamitsu Pharmaceutical Company, Inc., he has contributed significantly to innovative solutions in drug delivery methods.

Latest Patents

Sakakura holds a patent for a revolutionary gel patch known as a poultice. This invention comprises a paste layer that contains ketoprofen, a commonly used anti-inflammatory medication, along with propylene glycol, 1-menthol, and water. The unique formulation features a specific ratio where the mass of propylene glycol is capped at three times that of ketoprofen. Additionally, it incorporates 0.1 to 0.5 mass percent of 1-menthol based on the total mass of the paste layer, enhancing the patch's effectiveness and usability.

Career Highlights

Working at Hisamitsu Pharmaceutical Company, Inc., Tatsuya Sakakura has focused on creating advanced transdermal delivery systems that improve patient experiences with medications. His innovative approach demonstrates an understanding of both scientific principles and practical applications in healthcare.

Collaborations

Sakakura has collaborated with notable colleagues in his research endeavors, including Satoshi Kimura and Seiichiro Tsuru. Together, they explore and develop innovative pharmaceutical products that aim to revolutionize the way medications are delivered.

Conclusion

In conclusion, Tatsuya Sakakura stands as a prominent figure in the pharmaceutical innovation landscape. His work on the poultice gel patch illustrates the potential of translational research in improving drug administration and patient care. His contributions at Hisamitsu Pharmaceutical Company, Inc. indicate a commitment to advancing medical science and enhancing therapeutic options for patients.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…